Overview

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Status:
Completed

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

The aim of this dose-finding clinical trial is to evaluate the systemic tolerability, local tolerability and intraocular pressure lowering effect of three different doses of SYL040012 in subjects with ocular hypertension or open-angle glaucoma.

Phase:

Phase 2

Details

Lead Sponsor:

Sylentis, S.A.

Treatments:

Ophthalmic Solutions
Tetrahydrozoline